HIMS · NYSE
Hims & Hers Health (HIMS) Stock Price & Fundamentals
Hims & Hers Health (HIMS) closed at $324.08 on Oct 9, 2026, down 1.16% from the previous close of $327.87.
Share price, past year
1Y +22.75%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $324.08 |
| Sep 30, 2026 | $321.92 |
| Aug 31, 2026 | $326.59 |
| Jul 31, 2026 | $327.10 |
| Jun 30, 2026 | $320.46 |
| May 29, 2026 | $315.79 |
| Apr 30, 2026 | $327.79 |
| Mar 31, 2026 | $303.57 |
| Feb 27, 2026 | $288.93 |
| Jan 30, 2026 | $294.98 |
| Dec 31, 2025 | $300.92 |
| Nov 28, 2025 | $289.23 |
| Oct 31, 2025 | $270.88 |
Key statistics
- Market cap
- —
- P/E (TTM)
- —
- EPS (TTM)
- −$0.63
- Revenue (TTM)
- $2.58B
- Net income (TTM)
- −$142.03M
- Shares outstanding
- 0
- Dividend yield
- —
- 52-week range
- $262.33 – $340.97
Financials
Hims & Hers Health reported revenue of $2.35B for fiscal 2025, up 59.00% from fiscal 2024.
Hims & Hers Health earned net income of $128.37M in fiscal 2025, a net margin of 5.5%.
Fiscal 2025 revenue was the highest in the 7 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $2.35B | +59.0% | $128.37M | 5.5% | $0.51 | — |
| FY2024ended Dec 31, 2024 | $1.48B | +69.3% | $126.04M | 8.5% | $0.53 | — |
| FY2023ended Dec 31, 2023 | $872.00M | +65.5% | −$23.55M | −2.7% | −$0.11 | — |
| FY2022ended Dec 31, 2022 | $526.92M | +93.8% | −$65.68M | −12.5% | −$0.32 | — |
| FY2021ended Dec 31, 2021 | $271.88M | +82.8% | −$107.66M | −39.6% | −$0.58 | — |
| FY2020ended Dec 31, 2020 | $148.76M | +80.2% | −$18.11M | −12.2% | −$0.51 | — |
| FY2019ended Dec 31, 2019 | $82.56M | — | −$72.06M | −87.3% | −$2.07 | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $753.21M | −$86.29M | −$0.37 |
| Q1 FY2026ended Mar 31, 2026 | $608.10M | −$92.12M | −$0.40 |
| Q4 FY2025ended Dec 31, 2025 | $617.82M | $20.60M | $0.08 |
| Q3 FY2025ended Sep 30, 2025 | $598.98M | $15.77M | $0.06 |
| Q2 FY2025ended Jun 30, 2025 | $544.83M | $42.51M | $0.17 |
| Q1 FY2025ended Mar 31, 2025 | $586.01M | $49.49M | $0.20 |
| Q4 FY2024ended Dec 31, 2024 | $481.14M | $26.03M | $0.10 |
| Q3 FY2024ended Sep 30, 2024 | $401.56M | $75.59M | $0.32 |
Company profile
- Name
- Hims & Hers Health, Inc.
- Ticker
- HIMS
- Exchange
- NYSE
- Industry (SEC SIC)
- Services-Offices & Clinics of Doctors of Medicine
- Headquarters
- 2269 Chestnut St, #523, San Francisco, CA 94123
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001773751
Recent SEC filings
- Oct 7, 2026
- Aug 10, 2026
- Aug 10, 2026
- Jul 17, 2026
- Jul 1, 2026
- Jun 15, 2026
- Jun 2, 2026
- May 21, 2026
Frequently asked questions
What is Hims & Hers Health's stock price?
Hims & Hers Health (HIMS) closed at $324.08 on Oct 9, 2026, down 1.16% from the previous close of $327.87.
How much revenue does Hims & Hers Health make?
Hims & Hers Health reported revenue of $2.35B for fiscal 2025, up 59.00% from fiscal 2024.
Does Hims & Hers Health pay a dividend?
Hims & Hers Health's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Hims & Hers Health, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures